A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

By M. Malinchoc, P. Kamath, F. Gordon, C. Peine, J. Rank, P. T. ter Borg. Hepatology, 2000

2,821 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

EASL Clinical Practice Guidelines: Liver transplantation. (2016, background): “The MELD was developed to determine the short-term prognosis for patients undergoing TIPS after gastrointestinal bleeding [10], and then proposed for predicting 3-month mortality in patients with end-stage liver disease.”
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. (2018, background): “A score system based on SCr, INR, serum bilirubin and aetiology of cirrhosis has been proposed to predict survival after TIPS insertion for refractory ascites [112].”
Guidelines on the management of ascites in cirrhosis (2006, background): “120 Model for end stage liver disease score, which was originally developed to predict survival following a TIPS procedure, 121 has continued to evolve into a model that predicts prognosis in cirrhosis.”
Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. (2014, methodology): “Results From 2002-2012, there were 61,868 adult LT recipients in the U.S., including 10,061 HCC patients that received LT.”
The Survival Benefit of Liver Transplantation (2005, background): “The Board of Directors of the OPTN recently approved such a modification to the national allocation system for deceased donor livers in the United States (22).”